Literature DB >> 2828366

All four repeating domains of the endogenous inhibitor for calcium-dependent protease independently retain inhibitory activity. Expression of the cDNA fragments in Escherichia coli.

Y Emori1, H Kawasaki, S Imajoh, Y Minami, K Suzuki.   

Abstract

We have already determined the primary structure of the endogenous inhibitor for calcium-dependent protease (CANP inhibitor, calpastatin) from the cDNA sequence and revealed that the CANP inhibitor contains four internally repeating units which could be responsible for its multiple reactive sites (Emori, Y., Kawasaki, H., Imajoh, S., Imahori, K., and Suzuki, K. (1987) Proc. Natl. Acad. Sci. U.S.A. 84, 3590-3594). Restriction fragments of the cDNA corresponding to each of the four domains (encoding 104-156 amino acid residues of the total 718 residues) were subcloned into the multicloning site of pUC9 or pUC18 in a direction and frame matched to the lacZ' open reading frame of the vector. Under the lac operator-promoter system, we succeeded in producing truncated fragments of the CANP inhibitor in Escherichia coli. The CANP inhibitor fragments were partially purified, and the inhibitory activities toward calcium-dependent protease (CANP) were examined. All fragments containing well conserved regions of about 30 amino acid residues (domains I-IV) located in the middle of the four units exhibited the inhibitory activity. However, their inhibitory activities varied considerably. Further truncation experiments revealed that small fragments containing 30-70 amino acid residues of the CANP inhibitor still retained inhibitory activity. From these experimental results the following conclusions can be drawn: 1) each of the four repeating units of the CANP inhibitor (about 140 amino acid residues) is a real functional unit and can inhibit CANP activity independently; and 2) domains corresponding to well conserved sequences of about 30 amino acid residues containing a consensus Thr-Ile-Pro-Pro-X-Tyr-Arg sequence are essential for the inhibitory activity, and the bordering regions are important for its modulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2828366

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Effects of nuclear factor I phosphorylation on calpastatin (CAST) gene variant expression and subcellular distribution in malignant glioma cells.

Authors:  The Minh Vo; Rebecca Burchett; Miranda Brun; Elizabeth A Monckton; Ho-Yin Poon; Roseline Godbout
Journal:  J Biol Chem       Date:  2018-11-30       Impact factor: 5.157

2.  NMR relaxation studies on the hydrate layer of intrinsically unstructured proteins.

Authors:  Mónika Bokor; Veronika Csizmók; Dénes Kovács; Péter Bánki; Peter Friedrich; Peter Tompa; Kálmán Tompa
Journal:  Biophys J       Date:  2004-12-21       Impact factor: 4.033

3.  Constant expression of mouse calpastatin isoforms during differentiation in myoblast cell line, C2C12.

Authors:  K Hitomi; M Murase; T Kawamura; M Maki
Journal:  Cytotechnology       Date:  2000-07       Impact factor: 2.058

Review 4.  Calpain system and its involvement in myocardial ischemia and reperfusion injury.

Authors:  Christiane Neuhof; Heinz Neuhof
Journal:  World J Cardiol       Date:  2014-07-26

5.  Role of calpain in skeletal-muscle protein degradation.

Authors:  J Huang; N E Forsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

6.  Isolation and characterization of a gamma-type phosphoinositide-specific phospholipase C (PLC-gamma 2).

Authors:  Y Homma; Y Emori; F Shibasaki; K Suzuki; T Takenawa
Journal:  Biochem J       Date:  1990-07-01       Impact factor: 3.857

Review 7.  High molecular mass intracellular proteases.

Authors:  A J Rivett
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

8.  A novel polymorphisms in intron 12 of the bovine calpastatin gene.

Authors:  Edyta Juszczuk-Kubiak; Joanna Wyszyńska-Koko; Krystyna Wicińska; Stanisław Rosochacki
Journal:  Mol Biol Rep       Date:  2007-01-09       Impact factor: 2.316

9.  Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.

Authors:  N Després; G Talbot; B Plouffe; G Boire; H A Ménard
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Binding-induced folding transitions in calpastatin subdomains A and C.

Authors:  Zoltán Mucsi; Ferenc Hudecz; Miklós Hollósi; Peter Tompa; Peter Friedrich
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.